The DOI matches its Crossref record; 456 of the 456 references it cites were found in a registry or an index.
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Open accessAbstract
Metastasis remains a pivotal characteristic of cancer and is the primary contributor to cancer-associated mortality. Despite its significance, the mechanisms governing metastasis are not fully elucidated. Contemporary findings in the domain of cancer biology have shed light on the molecular aspects of this intricate process. Tumor cells undergoing invasion engage with other cellular entities and proteins en route to their destination. Insights into these engagements have enhanced our comprehension of the principles directing the movement and adaptability of metastatic cells. The tumor microenvironment plays a pivotal role in facilitating the invasion and proliferation of cancer cells by enabling tumor cells to navigate through stromal barriers. Such attributes are influenced by genetic and epigenetic changes occurring in the tumor cells and their surrounding milieu. A profound understanding of the metastatic process’s biological mechanisms is indispensable for devising efficacious therapeutic strategies. This review delves into recent developments concerning metastasis-associated genes, important signaling pathways, tumor microenvironment, metabolic processes, peripheral immunity, and mechanical forces and cancer metastasis. In addition, we combine recent advances with a particular emphasis on the prospect of developing effective interventions including the most popular cancer immunotherapies and nanotechnology to combat metastasis. We have also identified the limitations of current research on tumor metastasis, encompassing drug resistance, restricted animal models, inadequate biomarkers and early detection methods, as well as heterogeneity among others. It is anticipated that this comprehensive review will significantly contribute to the advancement of cancer metastasis research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 456
Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome
Su, H., Yang, F., Fu, R., Trinh, B., Sun, N., Liu, J., Kumar, A., Baglieri, J., Siruno, J., Le, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05169-z · Cited by 221
TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Mohammad, K. S., Javelaud, D., Fournier, P. G. J., Niewolna, M., McKenna, C. R., Peng, X. H., Duong, V., Dunn, L. K., Mauviel, A., & Guise, T. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2651 · Cited by 221
Rosewell Shaw, A., Porter, C. E., Watanabe, N., Tanoue, K., Sikora, A., Gottschalk, S., Brenner, M. K., & Suzuki, M. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.09.010 · Cited by 219
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway
Chen, J., Ding, C., Chen, Y., Hu, W., Yu, C., Peng, C., Feng, X., Cheng, Q., Wu, W., Lu, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.019 · Cited by 219
Muro, K., Boku, N., Shimada, Y., Tsuji, A., Sameshima, S., Baba, H., Satoh, T., Denda, T., Ina, K., Nishina, T., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70181-9 · Cited by 215
Xie, M., Lin, Z., Ji, X., Luo, X., Zhang, Z., Sun, M., Chen, X., Zhang, B., Liang, H., Liu, D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.036 · Cited by 212
NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis
Park, M. K., Zhang, L., Min, K.-W., Cho, J.-H., Yeh, C.-C., Moon, H., Hormaechea-Agulla, D., Mun, H., Ko, S., Lee, J. W., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.011 · Cited by 210
An analysis of genetic heterogeneity in untreated cancers
Reiter, J. G., Baretti, M., Gerold, J. M., Makohon-Moore, A. P., Daud, A., Iacobuzio-Donahue, C. A., Azad, N. S., Kinzler, K. W., Nowak, M. A., & Vogelstein, B. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0185-x · Cited by 209
Kratzer, T. B., Jemal, A., Miller, K. D., Nash, S. H., Wiggins, C. L., Redwood, D. G., Smith, R. A., & Siegel, R. L. (2022) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21757 · Cited by 204
Tang, H., Xu, X., Chen, Y., Xin, H., Wan, T., Li, B., Pan, H., Li, D., & Ping, Y. (2021) · Advanced Materials · doi:10.1002/adma.202006003 · Cited by 203
Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies
Li, J., Li, J., Peng, Y., Du, Y., Yang, Z., & Qi, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.053 · Cited by 201
Kammula, U. S., White, D. E., & Rosenberg, S. A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m · Cited by 200
Yu, Y., Nangia-Makker, P., Farhana, L., & Majumdar, A. P. N. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0725-5 · Cited by 198
Smart Nanotherapeutic Targeting of Tumor Vasculature
Li, Z., Di, C., Li, S., Yang, X., & Nie, G. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00283 · Cited by 196
Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis
Li, Z., Wang, D., Lu, J., Huang, B., Wang, Y., Dong, M., Fan, D., Li, H., Gao, Y., Hou, P., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-00615-9 · Cited by 196
He, Z., Wang, J., Zhu, C., Xu, J., Chen, P., Jiang, X., Chen, Y., Jiang, J., & Sun, C. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215751 · Cited by 196
Modest, D. P., Martens, U. M., Riera-Knorrenschild, J., Greeve, J., Florschütz, A., Wessendorf, S., Ettrich, T., Kanzler, S., Nörenberg, D., Ricke, J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01340 · Cited by 193
Pein, M., Insua-Rodríguez, J., Hongu, T., Riedel, A., Meier, J., Wiedmann, L., Decker, K., Essers, M. A. G., Sinn, H.-P., Spaich, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15188-x · Cited by 191
DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis
Deng, J., Kang, Y., Cheng, C.-C., Li, X., Dai, B., Katz, M. H. G., Men, T., Kim, M. P., Koay, E. J., Huang, H., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146133 · Cited by 189
FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism
Zhang, C., Liao, Y., Liu, P., Du, Q., Liang, Y., Ooi, S., Qin, S., He, S., Yao, S., & Wang, W. (2020) · Theranostics · doi:10.7150/thno.44868 · Cited by 186
Chen, M. B., Hajal, C., Benjamin, D. C., Yu, C., Azizgolshani, H., Hynes, R. O., & Kamm, R. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715932115 · Cited by 183 · cited 1×
“Given the selectivity of alpha particles, systemic radiation is speci fi cally delivered to cancer cells.”
BackgroundDoes the mobilization of circulating tumour cells during cancer therapy cause metastasis?
Martin, O. A., Anderson, R. L., Narayan, K., & MacManus, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.128 · Cited by 182
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
Vanpouille-Box, C., Pilones, K. A., Wennerberg, E., Formenti, S. C., & Demaria, S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.105 · Cited by 177
The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
Kopetz, S., Lemos, R., & Powis, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2408 · Cited by 176
TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
Slattery, K., Woods, E., Zaiatz-Bittencourt, V., Marks, S. J., Chew, S. M., Conroy, M. R., Goggin, C., Eochagáin, C. M., Kennedy, J., Lucas, S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002044 · Cited by 176
Development of immune checkpoint therapy for cancer
Fritz, J. M., & Lenardo, M. J. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182395 · Cited by 175
Zheng, X., Wang, X., Cheng, X., Liu, Z., Yin, Y., Li, X., Huang, Z., Wang, Z., Guo, W., Ginhoux, F., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00599-8 · Cited by 172 · cited 1×
“125 Xiaocui Zheng et al. 126 presented a single-cell landscape of the ovarian cancer (OC) ecosystem, highlighting fi ve tumor-relevant areas such as malignant ascites and omentum metastases.”
BackgroundSelf-citationAged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis
Yang, C., Wang, Z., Li, L., Zhang, Z., Jin, X., Wu, P., Sun, S., Pan, J., Su, K., Jia, F., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002875 · Cited by 172
Self-citationMitochondria-localized cGAS suppresses ferroptosis to promote cancer progression
Qiu, S., Zhong, X., Meng, X., Li, S., Qian, X., Lu, H., Cai, J., Zhang, Y., Wang, M., Ye, Z., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00788-1 · Cited by 172
Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
Zhang, P., Zhai, Y., Cai, Y., Zhao, Y., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201904156 · Cited by 171
Siefker-Radtke, A. O., Necchi, A., Park, S. H., García-Donas, J., Huddart, R. A., Burgess, E. F., Fleming, M. T., Rezazadeh Kalebasty, A., Mellado, B., Varlamov, S., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00660-4 · Cited by 171
Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
Branco-Price, C., Zhang, N., Schnelle, M., Evans, C., Katschinski, D. M., Liao, D., Ellies, L., & Johnson, R. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.017 · Cited by 168 · cited 1×
“120 In a gastric cancer tumor co-culture system, gastric cancer cells induced lymphatic vessel endothelial cells (LECs) to secrete CXCL1 via the NF-κ B pathway.”
BackgroundNecroptosis‐Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy
Um, W., Ko, H., You, D. G., Lim, S., Kwak, G., Shim, M. K., Yang, S., Lee, J., Song, Y., Kim, K., et al. (2020) · Advanced Materials · doi:10.1002/adma.201907953 · Cited by 168
Mutant p53 on the Path to Metastasis
Tang, Q., Su, Z., Gu, W., & Rustgi, A. K. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.11.004 · Cited by 167
Tolaney, S. M., Barroso‐Sousa, R., Keenan, T. E., Li, T., Trippa, L., Vaz-Luís, I., Wulf, G. M., Spring, L. M., Sinclair, N. F., Andrews, C., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3524 · Cited by 167
The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis
Chandra, R., Karalis, J. D., Liu, C., Murimwa, G. Z., Voth Park, J., Heid, C. A., Reznik, S. I., Huang, E., Minna, J. D., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13246206 · Cited by 167
Ji, D., Song, C., Li, Y., Xia, J., Wu, Y., Jia, J., Cui, X., Yu, S., & Gu, J. F. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000826 · Cited by 166
Wu, H.-J., Hao, M., Yeo, S. K., & Guan, J.-L. (2020) · Oncogene · doi:10.1038/s41388-020-1162-2 · Cited by 165
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Escobar-Hoyos, L. F., Penson, A., Kannan, R., Cho, H., Pan, C.-H., Singh, R. K., Apken, L. H., Hobbs, G. A., Luo, R., Lecomte, N., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.010 · Cited by 162
Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis
Lai, S.-L., Chien, A. J., & Moon, R. T. (2009) · Cell Research · doi:10.1038/cr.2009.41 · Cited by 161
Zhou, Y., Lin, F., Wan, T., Chen, A., Wang, H., Jiang, B., Zhao, W., Liao, S., Wang, S., Li, G., et al. (2021) · Theranostics · doi:10.7150/thno.56490 · Cited by 161
Hu, T., Liu, H., Liang, Z., Wang, F., Zhou, C., Zheng, X., Zhang, Y., Song, Y., Hu, J., He, X., et al. (2020) · Theranostics · doi:10.7150/thno.40860 · Cited by 160
The role of RNA m5C modification in cancer metastasis
Zhang, Q., Liu, F., Chen, W., Miao, H., Liang, H., Liao, Z., Zhang, Z., & Zhang, B. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.61439 · Cited by 160
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Petroni, G., Buqué, A., Coussens, L. M., & Galluzzi, L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00415-5 · Cited by 160
Somaiah, N., Conley, A. P., Parra, E. R., Lin, H., Amini, B., Solis Soto, L., Salazar, R., Barreto, C., Chen, H., Gite, S., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00392-8 · Cited by 159 · cited 1×
“342 For instance, cyclic dinucleotide (CDN) agonists of the stimulator of interferon genes (STING) are emerging as potent immunotherapeutics.”
BackgroundCalvisi, D. F., Ladu, S., Conner, E. A., Seo, D., Hsieh, J.-T., Factor, V. M., & Thorgeirsson, S. S. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.036 · Cited by 159
Liu, Y., Ge, J., Chen, Y., Liu, T., Chen, L., Liu, C., Ma, D., Chen, Y., Cai, Y., Xu, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202205395 · Cited by 159
Zhang, Q., Liu, S., Wang, H., Xiao, K., Lu, J., Chen, S., Huang, M. X., Xie, R., Lin, T., & Chen, X. (2023) · Advanced Science · doi:10.1002/advs.202205613 · Cited by 159
Methylation multiplicity and its clinical values in cancer
Dai, X., Ren, T., Zhang, Y., & Nan, N. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.4 · Cited by 157
Zhou, Z., Wang, P., Sun, R., Li, J., Hu, Z., Xin, H., Luo, C., Zhou, J., Fan, J., & Zhou, S. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001946 · Cited by 156
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Badrinath, S., Dellacherie, M. O., Li, A. W., Zheng, S., Zhang, X., Sobral, M. C., Pyrdol, J. W., Smith, K. L., Lu, Y., Haag, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04772-4 · Cited by 156
Li, R., Liu, X., Huang, X., Zhang, D., Chen, Z., Zhang, J., Bai, R., Zhang, S., Zhao, H., Xu, Z., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-330243 · Cited by 153
Toh, T. B., Lim, J. J., Hooi, L., Rashid, M. B. M. A., & Chow, E. K. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.035 · Cited by 152
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Abufaraj, M. M., Dalbagni, G. M., Daneshmand, S., Horenblas, S., Kamat, A. M., Kanzaki, R., Zlotta, A. R., & Shariat, S. F. (2017) · European Urology · doi:10.1016/j.eururo.2017.09.030 · Cited by 150
Hu, Z., Sui, Q., Jin, X., Shan, G., Huang, Y., Yi, Y., Zeng, D., Zhao, M., Zhan, C., Wang, Q., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02989-x · Cited by 150
Du, Q., Liu, P., Zhang, C., Liu, T., Wang, W., Shang, C., Wu, J., Liao, Y., Chen, Y., Huang, J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04926-2 · Cited by 149
Mattiola, I., Tomay, F., Pizzol, M. D., Silva-Gomes, R., Savino, B., Gulić, T., Doni, A., Lonardi, S., Boutet, M., Nerviani, A., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0417-y · Cited by 147
He, Y., Jiang, X., Duan, L., Xiong, Q., Yuan, Y., Liu, P., Jiang, L., Shen, Q., Zhao, S., Yang, C., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01469-6 · Cited by 147
Xu, H., Zhao, J., Li, J., Zhu, Z., Cui, Z., Liu, R., Lu, R., Yao, Z., & Xu, Q. M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04935-1 · Cited by 147
Franchi, S., Panerai, A. E., & Sacerdote, P. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.01.001 · Cited by 145
Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers
Klotz, R. V., Thomas, A., Teng, T., Han, S. M., Iriondo, O., Li, L., Restrepo-Vassalli, S., Wang, A., Izadian, N., MacKay, M. J., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0384 · Cited by 145
Yu, D., Pan, M., Li, Y., Lu, T., Wang, Z., Liu, C., & Hu, G. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02212-1 · Cited by 143
Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression
Yang, B., Zhang, L., Cao, Y., Chen, S., Cao, J., Wu, D., Chen, J., Xiong, H., Pan, Z., Qiu, F., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0722-8 · Cited by 140
Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients
Liu, T., Liu, C., Yan, M., Zhang, L., Zhang, J., Xiao, M., Li, Z., Wei, X., & Zhang, H. (2022) · Nature Communications · doi:10.1038/s41467-022-34581-2 · Cited by 140
CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma
Li, J., Hu, Z., Yu, S., Mao, L., Zhou, Z., Wang, P., Gong, Y., Su, S., Zhou, J., Fan, J., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1259 · Cited by 139
Tian, S., Chu, Y., Hu, J., Ding, X., Liu, Z., Fu, D., Yuan, Y., Deng, Y., Wang, G., Wang, L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325137 · Cited by 137
Gong, Z., Li, Q., Shi, J., Li, P., Hua, L., Shultz, L. D., & Ren, G. (2023) · Science Immunology · doi:10.1126/sciimmunol.add5204 · Cited by 137
Gao, K., Li, X., Zhang, L., Bai, L., Dong, W., Gao, K., Shi, G., Xia, X., Wu, L., & Zhang, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.002 · Cited by 135
Jiang, K., Chen, H., Fang, Y., Chen, L., Zhong, C., Bu, T., Dai, S., Pan, X., Fu, D., Qian, Y., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01816-3 · Cited by 135
Liu, Q., Hodge, J., Wang, J., Wang, Y., Wang, L., Singh, U. P., Li, Y., Yao, Y., Wang, D., Ai, W., et al. (2020) · Theranostics · doi:10.7150/thno.45395 · Cited by 133
Jiang, T., Wang, H., Liu, L., Hu, S., Zhang, Y., Wang, J., Liu, L., Xu, T., Fan, R., Xu, Y., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01474-9 · Cited by 131
Self-citationAcute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis
Ben‐Eliyahu, S., Page, G. G., Yirmiya, R., & Taylor, A. (1996) · Nature Medicine · doi:10.1038/nm0496-457 · Cited by 128
Sun, Y., Hu, H., Liu, Z., Xu, J., Gao, Y., Zhan, X., Zhou, S., Zhong, W., Wu, D., Wang, P., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006481 · Cited by 128
Majid, S., Dar, A. A., Saini, S., Shahryari, V., Arora, S., Zaman, M. S., Chang, I., Yamamura, S., Tanaka, Y., Chiyomaru, T., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2952 · Cited by 126
Heme catabolism by tumor-associated macrophages controls metastasis formation
Consonni, F. M., Bleve, A., Totaro, M. G., Storto, M., Kunderfranco, P., Termanini, A., Pasqualini, F., Alì, C., Pandolfo, C., Sgambelluri, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00921-5 · Cited by 126
Thibaudin, M., Fumet, J.-D., Chibaudel, B., Bennouna, J., Borg, C., Martin-Babau, J., Cohen, R., Fonck, M., Taïeb, J., Limagne, E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02497-z · Cited by 125
Lv, M., Xu, Y., Tang, R., Ren, J., Shen, S., Chen, Y., Liu, B., Hou, Y., & Wang, T. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0448 · Cited by 124
Liu, X., Chen, Q., Yan, J. Y., Wang, Y., Zhu, C., Chen, C., Zhao, X., Xu, M., Sun, Q., Deng, R., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.458 · Cited by 124
A niche role for cancer exosomes in metastasis
Zhang, Y., & Wang, X.-F. (2015) · Nature Cell Biology · doi:10.1038/ncb3181 · Cited by 122
Self-citationGenome-wide analysis of somatic noncoding mutation patterns in cancer
Dietlein, F., Wang, A. B., Fagre, C. R., Tang, A., Besselink, N. J. M., Cuppen, E. P. J. G., Li, C., Sunyaev, S. R., Neal, J. T., & Allen, E. M. V. (2022) · Science · doi:10.1126/science.abg5601 · Cited by 121
Huang, X., Pang, M.-J., Li, J.-Y., Chen, H., Sun, J., Song, Y., Ni, H.-J., Ye, S.-Y., Bai, S., Li, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36310-9 · Cited by 121
Self-citationRong, D., Sun, G., Zheng, Z., Liu, L., Chen, X., Wu, F., Gu, Y., Dai, Y., Zhong, W., Hao, X., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70137 · Cited by 120
Self-citationEmmanuel, C., Chiew, Y.-E., George, J., Etemadmoghadam, D., Anglesio, M. S., Sharma, R. N., Russell, P., Kennedy, C. J., Fereday, S., Hung, J. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1292 · Cited by 118
An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness
Liu, L., Tao, T., Liu, S., Yang, X., Chen, X., Liang, J., Hong, R., Wang, W., Yang, Y., Li, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22971-x · Cited by 118
Dai, W., Xiang, W., Han, L., Yuan, Z., Wang, R., Ma, Y., Yang, Y. P., Cai, S., Xu, Y., Mo, S., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12341 · Cited by 118
Moose, D. L., Krog, B. L., Kim, T., Zhao, L. Q., Williams-Perez, S. M., Burke, G. S., Rhodes, L., Vanneste, M., Breheny, P. J., Milhem, M. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.080 · Cited by 116
Huggins, D. N., LaRue, R. S., Wang, Y., Knutson, T. P., Xu, Y., Williams, J. W., & Schwertfeger, K. L. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0101 · Cited by 114
Rokavec, M., Horst, D. A., & Hermeking, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3236 · Cited by 113
Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial α5 Integrin
Cao, Y., Hoeppner, L. H., Bach, S., Guangqi, E., Guo, Y., Wang, E., Wu, J., Cowley, M. J., Chang, D. K.-F., Waddell, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0529 · Cited by 112
Talimogene Laherparepvec for the Treatment of Advanced Melanoma
Ott, P. A., & Hodi, F. S. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2709 · Cited by 111
Hong, S., Zhang, Y., Yu, G., Peng, P., Peng, J., Jia, J., Wu, X., Huang, Y., Yang, Y., Lin, Q., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00396 · Cited by 111
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Stevens, L. E., Peluffo, G., Qiu, X., Temko, D., Fassl, A., Li, Z., Trinh, A. C., Seehawer, M., Jovanović, B., Alečković, M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0423 · Cited by 111
Liu, X., Hogg, G. D., Zuo, C., Borcherding, N. C., Baer, J. M., Lander, V. E., Kang, L., Knolhoff, B. L., Ahmad, F. F., Osterhout, R. E., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.04.018 · Cited by 111
Harnessing cancer immunotherapy during the unexploited immediate perioperative period
Matzner, P., Sandbank, E., Neeman, E., Zmora, O., Gottumukkala, V. N. R., & Ben‐Eliyahu, S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0319-9 · Cited by 110
Yu, B., Luo, F., Sun, B., Liu, W., Shi, Q., Cheng, S., Chen, C., Chen, G., Li, Y., & Feng, H. (2021) · Advanced Science · doi:10.1002/advs.202100014 · Cited by 110
Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules
Liu, Y., Zhang, Y., Ding, Y., & Zhuang, R. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103502 · Cited by 109
Zhang, Y., Yu, H. T., Zhang, J., Gao, H., Wang, S., Li, S., Wei, P., Liang, J., Yu, G., Wang, X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146187 · Cited by 108
Self-citationZhang, G., Gao, Z.-X., Guo, X., Ma, R., Wang, X., Zhou, P., Li, C., Tang, Z., Zhao, R., & Gao, P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166224 · Cited by 105
Self-citationWang, M., Qin, Z., Yan, Y., Yan, Y., Duan, X., Yao, X., Jiang, Z., Li, W., & Qin, Z. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03196-3 · Cited by 104
Role of dendritic cells in progression and clinical outcome of colon cancer
Gulubova, M. V., Ananiev, J. R., Vlaykova, T. I., Yovchev, Y., Tsoneva, V., & Manolova, I. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1334-1 · Cited by 103
Brackett, C. M., Kojouharov, B., Veith, J. M., Greene, K. F., Burdelya, L. G., Gollnick, S. O., Abrams, S. I., & Gudkov, A. V. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521359113 · Cited by 103
Nicolay, J. P., Müller‐Decker, K., Schroeder, A., Brechmann, M., Möbs, M., Géraud, C., Assaf, C., Goerdt, S., Krammer, P. H., & Gülow, K. (2016) · Blood · doi:10.1182/blood-2016-01-694117 · Cited by 103
MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma
Maddipati, R., Norgard, R. J., Baslan, T., Rathi, K. S., Zhang, A. X. W., Saeid, A., Higashihara, T., Wu, F., Kumar, A., Annamalai, V., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1826 · Cited by 102
Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer
Li, N., Zhang, X., Zhou, J., Li, W., Shu, X., Wu, Y. C., & Long, M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114448 · Cited by 102
Larráyoz, M., Garcia-Barchino, M. J., Celay, J., Etxebeste, A., Jiménez, M., Pérez, C., Ordóñez, R., Cobaleda, C., Botta, C., Fresquet, V., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02178-3 · Cited by 101
Peng, S., Li, Y., Huang, M., Tang, G., Xie, Y., Chen, D., Hu, Y., Yu, T., Cai, J. Q., Yuan, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68484 · Cited by 100
Ma, S., Fu, A., Chiew, G. G. Y., & Luo, K. Q. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.001 · Cited by 99
Neutrophil Extracellular Traps (NETs) in Cancer Metastasis
Kaltenmeier, C., Simmons, R. L., Tohme, S. T., & Yazdani, H. O. (2021) · Cancers · doi:10.3390/cancers13236131 · Cited by 99
Li, Y., Li, B., Xu, Y., Qian, L., Xu, T., Meng, G., Li, H., Wang, Y., Zhang, L., Jiang, X. W., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0042 · Cited by 99
Ren, L., Yi, J., Yang, Y., Li, W., Zheng, X., Liu, J., Li, S., Yang, H. S., Zhang, Y., Ge, B., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106376 · Cited by 98
Self-citationPET in the management of locally advanced and metastatic NSCLC
Grootjans, W., de Geus-Oei, L.-F., Troost, E. G. C., Visser, E. P., Oyen, W. J. G., & Bussink, J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.75 · Cited by 97
CTC clusters induced by heparanase enhance breast cancer metastasis
Wei, R., Sun, D., Yang, H. Y., Yan, J., Zhang, X., Zheng, X., Fu, X., Geng, M., Huang, X., & Ding, J. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.189 · Cited by 97
Kopanja, D., Pandey, A., Kiefer, M. M., Wang, Z., Chandan, N., Carr, J. R., Franks, R. R., Yu, D., Guzman, G., Maker, A. V., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.023 · Cited by 93
Lin, Y., Qin, S., Li, Z., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6268 · Cited by 92
Perez, E. A., Awada, A. H., O’Shaughnessy, J., Rugo, H. S., Twelves, C. J., Im, S., Gómez-Pardo, P., Schwartzberg, L. S., Dieras, V. C., Yardley, D. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00332-0 · Cited by 91
Zhuo, W., Luo, C. T., Wang, X., Song, X., Fu, Y., & Luo, Y. (2010) · The Journal of Pathology · doi:10.1002/path.2760 · Cited by 90
Self-citationVariants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer
Ocker, M., Neureiter, D., Lueders, M., Zopf, S., Ganslmayer, M., Hahn, E. G., Herold, C., & Schuppan, D. (2005) · Gut · doi:10.1136/gut.2004.056192 · Cited by 90
SnapShot: Cancer Immunotherapy with Oncolytic Viruses
Gujar, S. A., Bell, J. C., & Diallo, J. (2019) · Cell · doi:10.1016/j.cell.2019.01.051 · Cited by 90
First in‐vivo human imaging at 10.5T: Imaging the body at 447 MHz
He, X., Ertürk, M. A., Grant, A., Wu, X., Lagore, R., DelaBarre, L. J., Eryaman, Y., Adriany, G., Auerbach, E. J., de Moortele, P. V., et al. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28131 · Cited by 90
Fasching, P. A., Yadav, S., Hu, C., Wunderle, M., Häberle, L., Hart, S. N., Rübner, M., Polley, E. C., Lee, K. Y., Gnanaolivu, R. D., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01200 · Cited by 90
Li, J., Wang, S., Wang, N., Zheng, Y., Yang, B., Wang, X., Zhang, J., Pan, B., & Wang, Z. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00775-2 · Cited by 90
Self-citationZheng, Y., Wang, N., Wang, S., Zhang, J., Yang, B., & Wang, Z. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02696-z · Cited by 88
The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor
Lee, J. T., Beliakoff, J., & Sun, Z.-J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm476 · Cited by 87
Colomb, F., Wang, W., Simpson, D. M., Zafar, M., Beynon, R. J., Rhodes, J. M., & Yu, L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.783431 · Cited by 87
Piper, M., Hoen, M., Darragh, L. B., Knitz, M. W., Nguyen, D., Gadwa, J., Durini, G., Hutter-Karakoc, I., Grier, A., Neupert, B., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.04.001 · Cited by 87
Recouvreux, M. V., Grenier, S. F., Zhang, Y., Esparza, E., Lambies, G., Galapate, C. M., Maganti, S., Duong‐Polk, K., Bhullar, D., Naeem, R. F., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00649-1 · Cited by 86
Raymant, M., Astuti, Y., Álvaro‐Espinosa, L., Green, D. M., Quaranta, V., Bellomo, G., Glenn, M. A., Chandran-Gorner, V., Palmer, D. H., Halloran, C. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47949-3 · Cited by 86
Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review
Dummer, R., Ascierto, P. A., Nathan, P., Robert, C., & Schadendorf, D. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4401 · Cited by 85
Chang, C.-Y., You, R., Armstrong, D., Bandi, A., Cheng, Y.-T., Burkhardt, P. M., Becerra-Dominguez, L., Madison, M. C., Tung, H.-Y., Zeng, Z., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0615 · Cited by 85
Wu, Q., Tian, P., He, D., Jia, Z., He, Y., Luo, W., Lv, X., Wang, Y., Zhang, P., Liang, Y., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00810-6 · Cited by 84
Xu, J., Zhang, C., He, Y., Wu, H., Wang, Z., Wu, S., Li, W., He, W., Cai, S., & Zhan, W.-H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26035 · Cited by 82
Gene Expression Profiling of Breast Cancer Brain Metastasis
Lee, J. Y., Park, K., Lee, E., Ahn, T., Jung, H. H., Lim, S. H., Hong, M. E., Do, I., Cho, E. Y., Kim, D., et al. (2016) · Scientific Reports · doi:10.1038/srep28623 · Cited by 82
Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis.
Lin, Q., Zhou, C., Bai, M., Zhu, D., Chen, J., Wang, H., Li, M., Wu, C., Li, Z., & Huang, M. (2020) · PubMed · Cited by 82
Paizal, J. P., Au, S. H., & Bakal, C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01176-x · Cited by 82
Sun, H., Zhang, L., Wang, Z., Gu, D., Zhu, M., Cai, Y., Li, L., Tang, J., Huang, B., Bosco, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41318-2 · Cited by 82
Self-citationEggers, J. P., Grandgenett, P. M., Collisson, E. C., Lewallen, M. E., Tremayne, J. R., Singh, P. K., Swanson, B. J., Andersen, J. M., Caffrey, T. C., High, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2288 · Cited by 81
Xue, B., Chuang, C.-H., Prosser, H. M., Fuziwara, C. S., Chan, C., Sahasrabudhe, N. S., Kühn, M., Wu, Y., Chen, J., Biton, A., et al. (2021) · Genes & Development · doi:10.1101/gad.347344.120 · Cited by 80
Yan, Z., Sheng, Z., Zheng, Y., Feng, R., Xiao, Q., Shi, L., Li, H., Yin, C., Luo, H., Hao, C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04409-w · Cited by 80
First Oncolytic Viral Therapy for Melanoma
Poh, A. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-nb2015-158 · Cited by 79
Lei, P., Pereira, E. R., Andersson, P., Amoozgar, Z., van Wijnbergen, J. W., O’Melia, M. J., Zhou, H., Chatterjee, S., Ho, W. W., Posada, J. M., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221847 · Cited by 79
Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer
Mu, Q., Lin, G., Jeon, M., Wang, H., Chang, F., Revia, R. A., Yu, J. S., & Zhang, M. (2021) · Materials Today · doi:10.1016/j.mattod.2021.08.002 · Cited by 78
Reprogramming of sentinel lymph node microenvironment during tumor metastasis
Li, Y.-L., & Hung, W. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00868-1 · Cited by 77
Hu, W., Liu, S.-Q., Zhu, K., Li, W., Yang, Z.-J., Yang, Q., Zhong-chao, Z., & Chang, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110505 · Cited by 77
Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis
Bolik, J., Krause, F., Stevanovic, M., Gandraß, M., Thomsen, I., Schacht, S.-S., Rieser, E., Müller, M., Schumacher, N., Fritsch, J., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201039 · Cited by 75
Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence
Wang, D., Xiao, F., Feng, Z., Li, M., Kong, L., Huang, L., Wei, Y., Li, H., Liu, F., Zhang, H., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01346-y · Cited by 73
Henrich, S. E., McMahon, K. M., Plebanek, M. P., Calvert, A. E., Feliciano, T. J., Parrish, S., Tavora, F., Mega, A. E., Souza, A. O., Carneiro, B. A., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12042 · Cited by 73
The Evolution of STING Signaling and Its Involvement in Cancer
Vashi, N., & Bakhoum, S. F. W. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.12.010 · Cited by 72
Tan, B., Zhou, K., Liu, W., Prince, E. A., Qing, Y., Li, Y., Han, L., Qin, X., Su, R. J., Pokharel, S. P., et al. (2022) · Theranostics · doi:10.7150/thno.71872 · Cited by 71
Garrison, K., Hahn, T., Lee, W., Ling, L. E., Weinberg, A. D., & Akporiaye, E. T. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1119-y · Cited by 70
Valle, J. W., Vogel, A., Denlinger, C. S., He, A. R., Bai, L., Орлова, Р. В., Cutsem, E. V., Adeva, J., Chen, L., Obermannova, R. L., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00409-5 · Cited by 70
Ye, X., Huang, X., Fu, X., Zhang, X., Lin, R., Zhang, W., Zhang, J., & Lü, Y. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01442-4 · Cited by 70
Chatterjee, A., Jana, S., Chatterjee, S., Wastall, L. M., Mandal, G., Nargis, N., Roy, H., Hughes, T. A., & Bhattacharyya, A. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0566-7 · Cited by 67
Regulatory T cells: Their role in triple‐negative breast cancer progression and metastasis
Malla, R. R., Vasudevaraju, P., Vempati, R. K., Rakshmitha, M., Merchant, N., & Nagaraju, G. P. (2022) · Cancer · doi:10.1002/cncr.34084 · Cited by 66
Young, P. A., Morrison, S. L., & Timmerman, J. M. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.08.002 · Cited by 66
Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer
Bhatia, V., Yadav, A., Tiwari, R., Nigam, S., Goel, S., Carskadon, S. L., Gupta, N., Goel, A., Palanisamy, N., & Ateeq, B. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3230 · Cited by 66
Orsini, G., Legitimo, A., Failli, A., Ferrari, P., Nicolini, A., Spisni, R., Miccoli, P., & Consolini, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122022 · Cited by 65
Künnapuu, J., Bokharaie, H., & Jeltsch, M. (2021) · Biology · doi:10.3390/biology10020167 · Cited by 65
Nambiar, D. K., Viswanathan, V., Cao, H., Zhang, W., Guan, L., Chamoli, M., Holmes, B., Kong, C. S., Hildebrand, R., Koong, A. J., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0046 · Cited by 64
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study
Bhatia, S., Curti, B. D., Ernstoff, M. S., Gordon, M. S., Heath, E. I., Miller, W. H., Puzanov, I. J., Quinn, D. I., Flaig, T. W., VanVeldhuizen, P. J., et al. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-2 · Cited by 63
Garnier, L., Pick, R., Montorfani, J., Sun, M., Brighouse, D., Liaudet, N., Kammertoens, T., Blankenstein, T. J. F., Pagé, N., Bernier‐Latmani, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl5162 · Cited by 63
Lawler, K., Foran, E., O’Sullivan, G. C., Long, A., & Kenny, D. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00626.2005 · Cited by 62
Jiang, J., Ye, F., Yang, X. F., Zong, C., Gao, L., Yang, Y., Zhao, Q., Han, Z., & Wei, L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.006 · Cited by 61
TAK1 regulates endothelial cell necroptosis and tumor metastasis
Yang, L., Joseph, S., Sun, T., Hoffmann, J. M., Thevissen, S., Offermanns, S., & Strilić, B. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-018-0271-8 · Cited by 61
Rodríguez, J., Álvarez, E. C., Perez‐Gracia, J. L., Rodríguez, I., Viúdez, A., Alfaro, C., Oñate, C., Pérez, G., Rotellar, F., Inogés, S., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0405-z · Cited by 59
Deng, Y., Tan, Y., Zhou, D., Bai, Y., Cao, T., Zhong, C., Huang, W., Ou, Y., Guo, L., Liu, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923194 · Cited by 58
CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells
Qiu, J., Li, X., Zeng, X., Wu, H., Liang, F., Lv, Q., & Du, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.972383 · Cited by 58
Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
Kim, Y., Yu, K.-M., Koh, J., Kim, E.-H., Kim, S., Kim, E. J., Casel, M. A. B., Rollon, R., Jang, S., Song, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27717-3 · Cited by 57
Xu, R., Lee, Y., Kim, C.-H., Min, G.-H., Kim, Y.-B., Park, J., Kim, D., Kim, J., & Yim, H. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02872-1 · Cited by 57
LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs
Su, M., Kumata, S., Endo, S., Okada, Y., & Takai, T. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2060907 · Cited by 55
Mao, Z., Wang, B., Zhang, T., & Cui, B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06265-2 · Cited by 55
Hanssen, A., Riebensahm, C., Mohme, M., Joosse, S. A., Velthaus, J.-L., Berger, L. A., Bernreuther, C., Glatzel, M., Loges, S., Lamszus, K., et al. (2018) · Cancers · doi:10.3390/cancers10120527 · Cited by 54
Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells
Vyas, M., Requesens, M., Nguyen, T. H., Peigney, D., Azin, M., & Demehri, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1098445 · Cited by 52
Grausam, K. B., Dooyema, S. D. R., Bihannic, L., Premathilake, H., Morrissy, A. S., Forget, A., Schaefer, A. M., Gundelach, J. H., Macura, S. I., Maher, D. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1836 · Cited by 51
Self-citationSwearingen, A. E. D. V., Siegel, M. B., Deal, A. M., Sambade, M. J., Hoyle, A. P., Hayes, D. N., Jo, H., Little, P., Dees, E. C., Muss, H. B., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4852-5 · Cited by 51
ANGPTL4 regulate glutamine metabolism and fatty acid oxidation in nonsmall cell lung cancer cells
Song, X., Nai‐dong, W., Jin‐Xiang, Y., Long, T., Lu, X., Hong, G., Jie‐Cheng, Y., & Fei, Z. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16879 · Cited by 51
Zhang, L., Zhang, C., Xing, Z., Lou, C., Fang, J., Wang, Z. P., Li, M., He, H., & Bai, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109420 · Cited by 51
Sun, G., Zhao, S., Fan, Z., Wang, Y., Liu, H., Cao, H., Sun, G., Huang, T., Cai, H., Pan, H., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02803-0 · Cited by 51
Self-citationRegulatory B cell: New member of immunosuppressive cell club
Ding, T., Fan, Y. L., Cao, S., & Ren, X. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.006 · Cited by 49
Ma, B., Wells, A. H., & Clark, A. M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.021 · Cited by 49
Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes
Li, Y.-L., Chen, C., Chen, J., Lai, Y.-S., Wang, S., Jiang, S. S., & Hung, W. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1830513 · Cited by 49
Margination and adhesion dynamics of tumor cells in a real microvascular network
Wang, S., Ye, T., Li, G., Zhang, X., & Shi, H. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008746 · Cited by 49
Ren, Y. T., Zhou, X., Liu, X., Jia, H.-H., Zhao, X., Wang, Q.-X., Han, L., Song, X., Zhu, Z.-Y., Sun, T., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.003 · Cited by 48
Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution
Wodarz, D., Newell, A. C., & Komarova, N. L. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0967 · Cited by 48
Venet, D., Fimereli, D., Rothé, F., Boeckx, B., Maetens, M., Majjaj, S., Rouas, G., Capra, M. C., Bonizzi, G., Contaldo, F., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102793 · Cited by 48
Yin, H., Lu, H., Xiong, Y., Ye, L., Teng, C., Cao, X., Li, S., Sun, S., Liu, W., Lv, W., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18660 · Cited by 48
Wu, Y., Gu, T., & Zheng, P. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.013 · Cited by 47
Piper, M., Court, B. V., Mueller, A. C., Watanabe, S., Bickett, T. E., Bhatia, S., Darragh, L. B., Mayeda, M., Nguyen, D., Gadwa, J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2767 · Cited by 47
Hou, D., Xiao, W., Wang, J., Muhammad, Y., Wang, Z., Fei, Y., Wang, M., Wang, L., Wang, H., Shi, X., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121523 · Cited by 47
Self-citationXia, C., Bai, W., Deng, T., Li, T., Zhang, L., Lu, Z., Zhang, Z., Li, M., & He, Q. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.01.009 · Cited by 47
Self-citationTGF-β signaling promotes cervical cancer metastasis via CDR1as
Zhong, G., Zhao, Q., Chen, Z., & Yao, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01743-9 · Cited by 47
Liu, B., Zhang, B., Qi, J., Zhou, H., Tan, L., Huang, J., Huang, J., Fang, X., Gong, L., Luo, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307914120 · Cited by 46
Self-citationTian, X., Cai, J., Ma, S., Fang, Y., Huang, H., Lin, T., Rao, H., Li, M., Xia, Z., Kang, T., et al. (2020) · 癌症:英文版 · doi:10.1002/cac2.12039 · Cited by 44
Alvarado-Estrada, K., Marenco-Hillembrand, L., Maharjan, S., Mainardi, V. L., Zhang, Y. S., Zarco, N., Schiapparelli, P. V., Guerrero‐Cazares, H., Sarabia-Estrada, R., Quiñones‐Hinojosa, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82634-1 · Cited by 44
Rawat, V., Malvi, P., Della Manna, D., Yang, E. S., Bugide, S., Zhang, X., Gupta, R., & Wajapeyee, N. (2021) · Oncogene · doi:10.1038/s41388-021-01683-y · Cited by 43 · cited 1×
“In vivo experiments demonstrated that high ASNS expression promoted nerve invasion and tumor metastasis.”
BackgroundmiRNA-346 promotes proliferation, migration and invasion in liver cancer
Yu, Q., Xia, Y., Duan, W., Li, C., Luo, Y., & Lu, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.6561 · Cited by 42
Han, X., Zhao, N., Zhu, W., Wang, J., Liu, B., & Teng, Y. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104423 · Cited by 42
Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche
Zhou, Y., Peng, K., Bao, X., Wu, H., Xia, Y., Zhang, Z., Zhong, H., Dai, Q., Wu, L., Wang, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30634-8 · Cited by 42
Li, R., Zhou, J., Wu, X., Li, H., Pu, Y., Liu, N., Han, Z., Zhou, L., Wang, Y., Zhu, H., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154082 · Cited by 41
MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3
Xue, M., Mi, S., Zhang, Z., Wang, H., Chen, W., Wei, W., & Lou, G. (2022) · Cancer Medicine · doi:10.1002/cam4.5561 · Cited by 41
Tropomodulin 3 modulates EGFR‐PI3K‐AKT signaling to drive hepatocellular carcinoma metastasis
Zheng, H., Yang, Y., Hong, Y., Wang, M., Yuan, S., Wang, Z., Bi, F., Hao, L., Yan, H., & Zhou, W. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23083 · Cited by 40
Metadata
- Authors
- Shi, X., Wang, X., Yao, W., Shi, D., Shao, X., Lu, Z., Chai, Y., Song, J., Tang, W., & Wang, X.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-08-02
- Volume
- 9
- Issue
- 1
- Pages
- 192-192
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4401280276
- Cited by
- 258
- References
- 456
- FWCI
- 39.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.